FDA Import Refusal SCS-8069752-3/10002/1 — UGURHAN
The FDA refused shipment SCS-8069752-3/10002/1 from UGURHAN (Turkey) on Mar 5, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 5, 2026
- Country
- Turkey
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75